Optimizing translation IBD capabilities: How to select the right preclinical model

18 Aug 2021

In this white paper, Crown Bioscience aims to improve the customer's understanding of the strengths, limitations, and differences across the range of available IBD models, which will help overcome the challenges associated with selecting and implementing the best translational model possible.

Links

Tags